Allergy/Asthma

Adults with asthma living in neighborhoods that were deprioritized for mortgage investments in the 1930s, or redlined, had worse lung function than those living in non-redlined areas, researchers reported.

Triple therapy, compared with dual therapy, was associated with fewer asthma exacerbations and modest improvements in asthma control in children and adults with moderate to severe asthma, according to a new meta-analysis.

Researchers said they have found evidence that children exposed to ultrafine particles from air pollution in utero were more likely to develop asthma than unexposed children.

May is Asthma and Allergy Awareness Month, “a perfect time” for primary care physicians to brush up on the best approaches to diagnosis and treatment, according the president-elect of the American College of Allergy, Asthma and Immunology.

Dupilumab significantly reduced asthma exacerbations and improved lung function within 2 weeks in children aged 6 to 11 years with uncontrolled moderate to severe asthma with evidence of type 2 inflammation.

Teens and young adults who report current e-cigarette use have increased risk for developing asthma and experiencing asthma exacerbations, according to data reported at the American Thoracic Society International Conference.

Children hospitalized for asthma exacerbations and treated with ibuprofen spend less time in the hospital than those treated with acetaminophen, data presented at the virtual Pediatric Academic Societies Annual Meeting showed.

May 5 is World Asthma Day. The Healio Editors have compiled a list of recent asthma news in recognition of World Asthma Day.

The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal polyps or chronic idiopathic urticaria, according to the manufacturers.

Researchers reported a significant decline in asthma exacerbations during the COVID-19 pandemic across all age groups, sexes and most regions in England.